Wellness vs Medical Claim Architecture

FDA Structure-Function Claim Limits

Also known as: Structure-Function Claims · Wellness Marketing · Supplement Marketing · Health Claim Architecture

Wellness vs medical claim architecture is the regulated brand-architecture category operating under the FDA Structure-Function Claims framework that distinguishes permissible wellness-product claims from prohibited unapproved-medical claims. The 1994 Dietary Supplement Health and Education Act (DSHEA) established the foundational framework — wellness products can claim "supports immune function" but cannot claim "treats infection," can claim "supports healthy cholesterol levels already in normal range" but cannot claim "lowers high cholesterol." The FDA Structure-Function Claims framework requires the "This statement has not been evaluated by the FDA" disclaimer alongside permissible claims plus prohibition of disease-treatment claims. Goop's September 4, 2018 FTC settlement ($145K, the Inner Judge essence and vaginal jade egg unapproved claims) set the wellness-brand FDA / FTC enforcement benchmark at industrial scale. AG1 (Athletic Greens) 2010-onward subscription-greens-powder positioning ($79 monthly subscription tier, Joe Rogan podcast sponsorship since the 2010s, Andrew Huberman partnership through 2024) demonstrated wellness-brand DTC architecture through celebrity-and-science positioning. Liver King × Brian Johnson 2018-2022 ancestral-diet positioning collapsed December 2022 following the leaked TestoLab steroid disclosure ("Liver King" admission of $11K monthly steroid usage despite the "ancestral diet only" positioning). The architecture matters because wellness brand marketing operates under the DSHEA framework that produces fundamentally different regulatory architecture than DTC pharma — substantially less stringent claim-substantiation requirements alongside FTC-and-state-AG enforcement risk.

The intellectual lineage runs through health-policy research and consumer-protection regulatory practitioner work. The 1994 DSHEA Act (with FDA Structure-Function Claims regulation 21 CFR 101.93), FDA Structure-Function Claims guidance documents, and the FTC Health Claims enforcement architecture provide the foundational regulatory frame. Goop's September 4, 2018 FTC settlement ($145K), the supplement-industry FTC enforcement cycles, and the FDA Office of Dietary Supplement Programs 2016-onward enforcement provide the empirical foundation. The post-2018 wellness-brand FTC enforcement cycle has produced a concentrated empirical case base.

How it works

Wellness brand marketing operates under the FDA Structure-Function Claims framework allowing permissible wellness-product claims while prohibiting unapproved-medical claims. The architecture produces creative-execution flexibility relative to the DTC pharma framework while operating under FTC-and-state-AG enforcement risk for overstated claims.

Three structural features determine effectiveness.

The first is the FDA Structure-Function Claims framework. Wellness brand marketing operates under 21 CFR 101.93 Structure-Function Claims framework permitting "supports normal function" claims while prohibiting disease-treatment claims. Permissible claims include "supports immune function," "promotes healthy aging," and "supports heart health" alongside the "This statement has not been evaluated by the FDA" disclaimer and the "Not intended to diagnose, treat, cure, or prevent any disease" disclaimer. The framework has remained the foundational regulatory architecture underneath the ~$50B+ annual US dietary-supplement industry across post-1994 cycles.

The second is FTC substantiation requirement. Wellness brand marketing claims must operate under the FTC substantiation requirement — "competent and reliable scientific evidence" supporting claims. The FTC enforcement architecture operates differently from the FDA Structure-Function Claims framework through claim-substantiation requirement rather than claim-prohibition requirement. The dynamic produces dual-regulatory-architecture risk where wellness brands navigate both FDA structure-function compliance and FTC substantiation compliance simultaneously.

The third is celebrity-credibility positioning architecture. Wellness brands frequently integrate celebrity-credibility positioning underneath the broader brand architecture. Gwyneth Paltrow × Goop (2008-onward), Joe Rogan × AG1 (Athletic Greens) podcast sponsorship, Andrew Huberman × AG1 partnership through 2024, Robb Wolf × LMNT electrolyte positioning, and Ryan Reynolds × Aviation American Gin operate as celebrity-credibility transfer architecture. The variant produces category credibility that traditional pharmaceutical wellness equivalents cannot easily replicate.

Variants

Subscription-supplement variant (Ritual, Care/of, AG1)

Monthly-subscription supplement architecture. Ritual (2016-onward, Katerina Schneider founder, "transparency" positioning), Care/of (2016-onward, Bayer subsidiary acquisition 2020), AG1 / Athletic Greens (2010-onward, $79 monthly subscription tier, Joe Rogan podcast sponsorship), Hum Nutrition (2013-onward), and Olly (2014-onward, Unilever acquisition 2019) canonicalize the variant.

Wellness-lifestyle brand variant (Goop, Moon Juice, Sakara)

Lifestyle-content integrated wellness-product architecture. Goop (2008-onward, Gwyneth Paltrow founder, Goop magazine 2017-2019, Goop Lab Netflix January 2020), Moon Juice (2012-onward, Amanda Chantal Bacon founder, $90 Moon Dust adaptogen-blend pricing), and Sakara Life (2011-onward, organic-meal-delivery $79+ daily-meal pricing) canonicalize the variant. The variant produces wellness-lifestyle category positioning at premium-pricing tiers.

Functional-mushroom and adaptogen variant (Four Sigmatic, Om Mushroom, Apothékary)

Mushroom-and-adaptogen positioning. Four Sigmatic (2012-onward, Tero Isokauppila founder, Lion's Mane / Reishi / Cordyceps mushroom-coffee variants), Om Mushroom Superfood (2012-onward), and Apothékary (2020-onward, Shizu Okusa founder, "alcohol alternative" positioning) canonicalize the variant. The variant has expanded substantially across the 2020-2024 wellness-cultural-moment integration.

Influencer-driven supplement variant (Liver King, Andrew Tate Real World)

Influencer-personality positioning. Liver King × Brian Johnson 2018-December 2022 collapse (the ancestral-diet positioning collapsed following the TestoLab steroid disclosure), Andrew Tate × Real World affiliate marketing (2022-onward), and the broader "bro science" influencer category demonstrate influencer-driven controversy patterns. The variant produces reputation-collapse risk that traditional brand-equity equivalents do not face.

Joe Rogan podcast-sponsorship cluster variant

Joe Rogan Experience sponsorship architecture. AG1 × Joe Rogan partnership, LMNT × Robb Wolf × Joe Rogan integration, and Onnit (Aubrey Marcus co-founder with Joe Rogan, Unilever acquisition 2021) canonicalize the cluster. The variant operates as a foundational wellness-brand distribution channel underneath the broader podcast-sponsorship architecture.

When it breaks

The primary failure is FTC enforcement against unsubstantiated claims. Wellness brands deploying unsubstantiated claims face structural FTC enforcement. Goop's September 2018 FTC settlement ($145K, the Inner Judge essence and vaginal jade egg unapproved claims), the 2019 Bayer One A Day Energy FTC settlement, and the 2020 Reckitt Move Free FTC settlement canonicalize the FTC enforcement architecture. The dynamic is foundational regulatory-architecture risk underneath broader wellness-brand operations.

The second failure is celebrity-positioning collapse following deception disclosure. Wellness brands anchored in celebrity positioning face structural reputation-collapse risk. Liver King × Brian Johnson's December 2022 TestoLab steroid disclosure ($11K monthly steroid usage despite the "ancestral diet only" positioning) set the celebrity-positioning collapse benchmark at industrial scale. The case is the canonical contemporary reference for influencer-driven supplement collapse.

The third failure is FDA Structure-Function Claims framework violation. Wellness brands crossing into prohibited disease-treatment claims face FDA enforcement. The 2010s-onward FDA warning letters against CBD-product disease-treatment claims, the 2020-2021 FDA warning letters against COVID-treatment claims (Silver Solutions / Vital Silver / adjacent silver-product COVID-claim warning letters), and FDA Office of Dietary Supplement Programs enforcement demonstrate Structure-Function Claims framework violation enforcement.

The most expensive failure is class-action litigation following overstated claims. Wellness brands deploying overstated claims face class-action litigation. The Reckitt Benckiser Mucinex Move Free 2020 class-action settlement, POM Wonderful's 2010s-onward FTC litigation cycles, and 5-Hour Energy's 2014 multi-state $4.3M settlement (33-state coalition over the "Hours of energy now / no crash later" overstated claims) demonstrate the class-action litigation cascade. The dynamic operates analogously to broader pharmaceutical settlement cascade frameworks.

In the wild

Played straight. A wellness brand commits to the FDA Structure-Function Claims framework, navigates FTC substantiation compliance, manages celebrity-credibility positioning through brand-substance investment, deploys disclaimer architecture across marketing, and treats wellness vs medical claim architecture as a foundational regulated-category platform. AG1 2010-onward "supports daily nutritional foundation" positioning and Ritual 2016-onward transparency positioning canonicalize the more sustainable wellness-brand variant.

Inverted. A consumer brand explicitly avoids wellness-claim positioning. Pharmaceutical-DTC brand operations (covered in entry 275) operate under the DTC pharma framework rather than the wellness-claim framework. "Snake oil" historical-cautionary positioning operates as alternative anti-wellness positioning.

Subverted. A wellness brand engages wellness-claim architecture meta-textually with audiences and trade — Liquid Death's brand-aware craft-marketing positioning that integrates wellness aesthetic at scale (covered in entry 280), Aviation American Gin's brand-aware celebrity-craft positioning.

Averted. A wellness brand declines to engage claim-architecture strategy and lets brand positioning drift through reactive product-only positioning, regardless of category-architecture opportunity dynamics.

Canonical examples

Goop FTC settlement (September 4, 2018, $145K)

Goop's September 4, 2018 FTC settlement ($145K, the Inner Judge essence and vaginal jade egg unapproved claims) set the wellness-brand FDA / FTC enforcement benchmark at industrial scale. Goop's 2008-onward Gwyneth Paltrow-led wellness-lifestyle brand architecture (Goop magazine 2017-2019 Conde Nast partnership, Goop Lab Netflix January 2020) navigated the FTC settlement and subsequent regulatory-architecture investment. The case is the canonical contemporary reference for wellness-brand FTC enforcement.

Liver King × Brian Johnson collapse (December 2, 2022)

Liver King × Brian Johnson's 2018-2022 ancestral-diet positioning collapsed December 2, 2022 following the leaked TestoLab steroid disclosure ("Liver King" admission of ~$11K monthly steroid usage including HGH, Anavar, and adjacent steroids despite the "ancestral diet only" positioning across 2018-2022). The collapse produced Ancestral Supplements brand-positioning navigation. The case is the canonical contemporary reference for influencer-driven supplement collapse failure mode.

AG1 / Athletic Greens (2010-onward, $1.2B+ valuation 2022)

Athletic Greens / AG1's 2010-onward subscription-greens-powder positioning ($79 monthly subscription tier, ~$1.2B+ valuation 2022 Series E round, Joe Rogan podcast sponsorship since the 2010s, Andrew Huberman partnership through 2023, Tim Ferriss / Lewis Howes / adjacent celebrity-and-science positioning)  set the subscription-supplement benchmark at industrial scale. The case is the canonical contemporary reference for the celebrity-driven subscription-supplement variant.

Ritual (2016-onward, Katerina Schneider transparency positioning)

Katerina Schneider's Ritual 2016-onward "transparency" positioning (sourcing-disclosure architecture, Ritual Essential for Women / Men / Pregnancy / Kid portfolio expansion) set the transparency-positioned subscription-supplement benchmark. Ritual's 2020 $80M+ Series C funding round demonstrated commercial scale. The case is the canonical reference for the transparency-positioned wellness-brand variant.

Care/of × Bayer acquisition (October 2020)

Care/of's October 2020 Bayer acquisition (terms undisclosed but reported $225M deal) set the pharmaceutical-major × wellness-DTC acquisition benchmark. Subsequent Bayer × Care/of 2021-2023 portfolio integration through the Care/of December 2023 shutdown announcement (effective February 2024) demonstrated the corporate-wellness-portfolio restructuring complications.

Olly × Unilever acquisition (April 2019)

Unilever's April 2019 Olly acquisition (terms undisclosed but reported $200M+ deal) set the CPG-major × wellness-DTC acquisition benchmark. Subsequent Unilever × Olly 2020-2024 portfolio expansion (Olly Sleep, Olly Goodbye Stress, and subsequent Olly portfolio expansion) demonstrated the sustainable wellness-brand corporate-integration variant.

Onnit × Unilever acquisition (March 2021)

Unilever's March 2021 Onnit acquisition (terms undisclosed but reported $400M+ deal) set the Joe Rogan podcast-sponsorship cluster acquisition benchmark. Aubrey Marcus's founder positioning (Joe Rogan co-founder) demonstrated the celebrity-driven wellness-brand corporate-acquisition pattern. The case is the canonical reference for the celebrity-cluster wellness-brand acquisition variant.

Moon Juice (2012-onward, Amanda Chantal Bacon, $90 Moon Dust)

Amanda Chantal Bacon's Moon Juice 2012-onward $90 Moon Dust adaptogen-blend pricing set the wellness-lifestyle category positioning at premium-pricing tiers. Moon Juice's Goop-adjacent positioning extended the wellness-lifestyle category architecture across post-2012 cycles.

5-Hour Energy multi-state $4.3M settlement (July 2014)

5-Hour Energy's July 2014 multi-state $4.3M settlement (33-state coalition over the "Hours of energy now / no crash later" overstated claims) set the class-action wellness-brand settlement benchmark. The case is the canonical reference for energy-supplement overstated-claims enforcement.

POM Wonderful FTC litigation (2010s-onward)

POM Wonderful's 2010s-onward FTC litigation (the 2010 FTC complaint over "30% reduced erectile dysfunction" / "40% reduced prostate cancer risk" overstated claims, with appeals through the 2015 DC Circuit Court ruling and the 2016 Supreme Court denial-of-cert) set the FTC-litigation cycle benchmark at industrial scale. The case is the canonical reference for the FTC-litigation wellness-brand framework.

Wellness vs medical claim architecture is the regulated brand-architecture category operating under the FDA Structure-Function Claims framework distinguishing permissible wellness-product claims from prohibited unapproved-medical claims. The wellness brands that understand the framework commit to FDA Structure-Function Claims compliance, navigate FTC substantiation compliance, manage celebrity-credibility positioning through brand-substance investment, deploy disclaimer architecture across marketing, and treat wellness vs medical claim architecture as a foundational regulated-category platform. The brands that don't understand the framework eat FTC enforcement against unsubstantiated claims, take celebrity-positioning collapse following deception disclosure, navigate FDA Structure-Function Claims framework violations, or face class-action litigation following overstated claims. The most-celebrated cautionary cases — Goop September 2018 $145K FTC settlement, Liver King December 2022 TestoLab steroid-disclosure collapse, POM Wonderful 2010s-onward FTC litigation — demonstrate the wellness-brand regulatory-architecture risk. The contemporary sustainable variants — AG1 2010-onward $1.2B+ valuation, Ritual 2016-onward transparency positioning, Onnit × Unilever / Olly × Unilever / Care/of × Bayer corporate-acquisition variants — share a structural commitment to Structure-Function Claims framework compliance with brand-substance investment.

Related insights

Wellness vs medical claim architecture is the foundational regulated brand-architecture framework adjacent to Direct-to-Consumer Pharma Marketing (entry 275), which operates under the fundamentally different DTC pharma framework rather than the wellness-claim framework. Mental Health Brand Marketing (entry 278), Cannabis Brand Strategy (entry 279), Alcohol Brand Marketing and Regulation (entry 280), and Vape and Nicotine Brand Marketing (entry 281) cover complementary regulated category frameworks. Manufactured Authenticity (entry 33) connects through wellness-brand authenticity-positioning failure modes (the Liver King collapse). Tourist Marketing (entry 27) provides the cautionary failure-mode framework for wellness-brand cultural positioning deployed without substance integration. Costly Signals (entry 22) connects through Structure-Function Claims framework compliance investment as a costly signal of regulatory-and-substance commitment. Crisis Pre-Positioning (entry 238) connects through brand-substance investment that subsequent FTC enforcement and celebrity-collapse navigation must build against. Apology Economics (entry 235) and Brand Exile (entry 237) cover crisis-response frameworks that wellness-brand controversy cycles trigger. Athlete Endorsement Architecture (entry 249) provides the broader celebrity-partnership framework underneath wellness-brand celebrity positioning. The broader pattern is that wellness brand marketing operates under the DSHEA Structure-Function Claims framework producing fundamentally different regulatory architecture than DTC pharma — substantially less stringent claim-substantiation requirements alongside FTC-and-state-AG enforcement risk. The strongest operations integrate Structure-Function Claims framework compliance with brand-substance investment that compounds across multi-year time horizons.